Saturday, December 21, 2024
12/21/2024
Siyan Clinical Research (SCR), a nonprofit clinic headquartered in Santa Rosa, CA, will expand Medications Assisted Treatment (MAT) to target crisis rates of opioid use disorders (OUD) among residents ages 18+ in rural areas of Northern California – specifically, in the opioid hot spot of Lake County, as well as Mendocino, Sonoma, and Marin Counties. Lake County is a particularly disadvantaged rural community where one in four people lives in poverty and 25% of residents are disabled (vs. 10.6% statewide). SCR is a division of Siyan Clinical Corporation, one of the largest psychiatric practices in Northern California. We deliver outpatient behavioral healthcare in an atmosphere of respect and compassion, with belief in the innate value of every individual. MAT programs are urgently needed to address the opioid epidemic in rural Northern California where opioid death rates are in shocking excess of the state average of only 11 deaths per 100,000. Lake County has been the hardest hit area here – the local opioid death rate was 36.6 persons per 100,000 population last year (double the number in 2014). This ranks Lake County as #5 in the U.S. in the number of opioid deaths. That exceeds opioid deaths in three of the most troubled eastern states – New Hampshire (36.3), Ohio (33.6), and Washington, D.C. (30.6), and it is nearing West Virginia (45.2) which has America's highest opioid death rate. Of all drug deaths here, 91% involved opioids. Lake County has also been identified by the CDC as one of 220 U.S. counties at risk for outbreaks of HIV and/or hepatitis C as a result of the opioid epidemic. The need for MAT programs here extends to Mendocino County, which has two deaths from unintentional opioid overdoses each month, and Sonoma County, where a resident dies of an opioid overdose every eight days. Our service region has a critical lack of publicly-funded opioid treatment facilities. To address the epidemic here, it's imperative that we increase the number of individuals with OUD receiving MAT and decrease illicit opioid drug use and prescription opioid misuse. In the state of California, even if all our waivered physicians prescribed MAT up to their limit, 100,000 Californians would still be without access. In our catchment area, the problem is an emergency. This region has 917,436 residents (Lake, Sonoma, Mendocino, and Marin Counties), and we have only one Hub and Spoke system (California’s new MAT Expansion Project) in Marin County and one in the city of Santa Rosa (Sonoma County). Dr. Anish Shah, M.D. (Chief Executive Officer of Siyan Clinical Research), will expand the SCR clinic's MAT program serving rural, underserved Northern California communities. This project will treat 300 adults with OUD from 9/29/2018 to 9/30/2021; an average of 100 annually. The program will use Suboxone (buprenorphine/naloxone daily tablet), Vivitrol (naloxone monthly injection), or naltrexone daily oral tablets to help patients manage opioid cravings and control opioid withdrawal. MAT will be delivered in conjunction with comprehensive, evidence-based psychosocial and recovery support services. These interventions will include: Motivational Interviewing/Motivational Enhancements (supported by use of the Stages of Change model; Cognitive Behavioral Therapy (individual and group; trauma-informed and gender-specific care; with Intensive Case Management, 12 Step Facilitation Therapy; and Relapse Prevention Therapy. All services will be guided by the current literature, including SAMHSA's Treatment Improvement Protocol 63: Medications for Opioid Use Disorder, as well as California state regulations for Office-Based Opioid Treatment (OBOT).
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).